TWI839458B - 在連續葡萄糖監測（ｃｇｍ）測量期間補償誤差的方法、製造ｃｇｍ裝置的方法及ｃｇｍ裝置 - Google Patents
在連續葡萄糖監測（ｃｇｍ）測量期間補償誤差的方法、製造ｃｇｍ裝置的方法及ｃｇｍ裝置 Download PDFInfo
- Publication number
- TWI839458B TWI839458B TW109103528A TW109103528A TWI839458B TW I839458 B TWI839458 B TW I839458B TW 109103528 A TW109103528 A TW 109103528A TW 109103528 A TW109103528 A TW 109103528A TW I839458 B TWI839458 B TW I839458B
- Authority
- TW
- Taiwan
- Prior art keywords
- current
- potential modulation
- sensor
- probe
- potential
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 154
- 239000008103 glucose Substances 0.000 title claims abstract description 154
- 238000000034 method Methods 0.000 title claims abstract description 69
- 238000012544 monitoring process Methods 0.000 title claims abstract description 67
- 238000005259 measurement Methods 0.000 title claims description 53
- 239000000523 sample Substances 0.000 claims abstract description 242
- 238000001514 detection method Methods 0.000 claims description 110
- 230000004044 response Effects 0.000 claims description 46
- 238000005070 sampling Methods 0.000 claims description 40
- 238000004590 computer program Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 2
- 239000012491 analyte Substances 0.000 abstract description 87
- 230000035945 sensitivity Effects 0.000 abstract description 62
- 230000000694 effects Effects 0.000 abstract description 31
- 238000011065 in-situ storage Methods 0.000 abstract description 23
- 238000004364 calculation method Methods 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 134
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 68
- 229960005489 paracetamol Drugs 0.000 description 34
- 230000009021 linear effect Effects 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 101100020663 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ppm-1 gene Proteins 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 230000007774 longterm Effects 0.000 description 11
- 101100352919 Caenorhabditis elegans ppm-2 gene Proteins 0.000 description 10
- 230000006399 behavior Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 238000004891 communication Methods 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 230000002452 interceptive effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000000737 periodic effect Effects 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 108010015776 Glucose oxidase Proteins 0.000 description 4
- 239000004366 Glucose oxidase Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940116332 glucose oxidase Drugs 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 229910021607 Silver chloride Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 238000004904 shortening Methods 0.000 description 3
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000002277 temperature effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000007772 electrode material Substances 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000004770 chalcogenides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
- A61B2560/0238—Means for recording calibration data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
- A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Emergency Medicine (AREA)
- Computer Networks & Wireless Communication (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962801592P | 2019-02-05 | 2019-02-05 | |
| US62/801,592 | 2019-02-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202045095A TW202045095A (zh) | 2020-12-16 |
| TWI839458B true TWI839458B (zh) | 2024-04-21 |
Family
ID=69570629
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109103528A TWI839458B (zh) | 2019-02-05 | 2020-02-05 | 在連續葡萄糖監測（ｃｇｍ）測量期間補償誤差的方法、製造ｃｇｍ裝置的方法及ｃｇｍ裝置 |
| TW113111424A TWI882745B (zh) | 2019-02-05 | 2020-02-05 | 用於探測連續分析物感測及自動校正的感測器操作的設備及方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW113111424A TWI882745B (zh) | 2019-02-05 | 2020-02-05 | 用於探測連續分析物感測及自動校正的感測器操作的設備及方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11737688B2 (enExample) |
| EP (2) | EP4417124A3 (enExample) |
| JP (2) | JP7494194B2 (enExample) |
| CN (1) | CN113490454A (enExample) |
| TW (2) | TWI839458B (enExample) |
| WO (1) | WO2020161099A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023536189A (ja) | 2020-08-04 | 2023-08-23 | アセンシア・ダイアベティス・ケア・ホールディングス・アーゲー | 分析物濃度を判定するための、定常状態条件及び非定常状態条件の膜構造を備えたバイオセンサ |
| US12490920B2 (en) * | 2021-06-11 | 2025-12-09 | Medtronic Minimed, Inc. | Adjustable glucose sensor initialization sequences |
| CN115877009A (zh) * | 2021-09-29 | 2023-03-31 | 苏州睿感医疗科技有限公司 | 持续血糖校正方法、装置和电子设备 |
| US12216074B2 (en) | 2021-10-01 | 2025-02-04 | Pacific Diabetes Technologies, Inc. | Biosensors and methods for determining analyte concentration in the kinetic potential region of redox mediators |
| CN114343629B (zh) * | 2021-11-17 | 2025-08-12 | 浙江凯立特医疗器械有限公司 | 传感器信号漂移自动跟踪矫正的方法及相关装置 |
| WO2024010827A1 (en) | 2022-07-05 | 2024-01-11 | Biolinq Incorporated | Sensor assembly of a microneedle array-based continuous analyte monitoring device |
| DE102022134580A1 (de) * | 2022-12-22 | 2024-06-27 | Endress+Hauser Conducta Gmbh+Co. Kg | Verfahren zum Kalibrieren eines Sensors im laufenden Betrieb, Sensor mit implementiertem Verfahren zur Kalibration |
| CN118642028B (zh) * | 2024-08-12 | 2024-10-18 | 陕西正泽生物技术有限公司 | 一种医用回旋加速器测磁霍尔探头校准方法及装置 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120283538A1 (en) * | 2011-05-06 | 2012-11-08 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
| CA3061574A1 (en) * | 2017-07-03 | 2019-01-10 | F. Hoffmann-La Roche Ag | Method and electronics unit for detecting in-vivo properties of a biosensor |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792668A (en) | 1993-08-06 | 1998-08-11 | Solid State Farms, Inc. | Radio frequency spectral analysis for in-vitro or in-vivo environments |
| DE60037592T2 (de) * | 1999-09-20 | 2009-01-22 | Roche Diagnostics Gmbh | Methode zur Messung eines Analyten mit Hilfe eines elektrochemischen Biosensors, der durch Anlegen eines Potentials abgeschaltet werden kann |
| US6885883B2 (en) | 2000-05-16 | 2005-04-26 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
| US20030235817A1 (en) | 2002-03-22 | 2003-12-25 | Miroslaw Bartkowiak | Microprocessors, devices, and methods for use in analyte monitoring systems |
| US8282549B2 (en) | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
| US8057401B2 (en) | 2005-02-24 | 2011-11-15 | Erich Wolf | System for transcutaneous monitoring of intracranial pressure |
| US20060094944A1 (en) | 2004-10-28 | 2006-05-04 | Sontra Medical Corporation | System and method for analyte sampling and analysis with error correction |
| CA2890945C (en) | 2005-07-20 | 2016-11-29 | Bayer Healthcare Llc | Gated amperometry |
| US8583205B2 (en) | 2008-03-28 | 2013-11-12 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
| US20080077015A1 (en) | 2006-05-17 | 2008-03-27 | Olga Boric-Lubecke | Determining presence and/or physiological motion of one or more subjects with multiple receiver Doppler radar systems |
| US8126554B2 (en) | 2006-05-17 | 2012-02-28 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor and related methods |
| US20070299617A1 (en) | 2006-06-27 | 2007-12-27 | Willis John P | Biofouling self-compensating biosensor |
| US20080234562A1 (en) * | 2007-03-19 | 2008-09-25 | Jina Arvind N | Continuous analyte monitor with multi-point self-calibration |
| US7783442B2 (en) * | 2007-10-31 | 2010-08-24 | Medtronic Minimed, Inc. | System and methods for calibrating physiological characteristic sensors |
| US9149220B2 (en) * | 2011-04-15 | 2015-10-06 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
| RU2509304C2 (ru) | 2008-12-08 | 2014-03-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Биосенсорная система с корректировкой сигнала |
| WO2011156152A1 (en) | 2010-06-07 | 2011-12-15 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
| JP6082396B2 (ja) | 2011-09-21 | 2017-02-15 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ | 誤差補償を伴うバイオセンサ |
| WO2014046318A1 (ko) * | 2012-09-21 | 2014-03-27 | ㈜ 더바이오 | 시료를 인식하는 방법 및 이를 이용한 바이오센서 |
| EP3662833B1 (en) | 2013-02-20 | 2025-06-04 | Dexcom, Inc. | Retrospective retrofitting method to generate a continuous glucose concentration profile |
| US9486171B2 (en) | 2013-03-15 | 2016-11-08 | Tandem Diabetes Care, Inc. | Predictive calibration |
| US20150073718A1 (en) | 2013-09-10 | 2015-03-12 | Lifescan Scotland Limited | Phase-difference determination using test meter |
| WO2015187366A1 (en) | 2014-06-06 | 2015-12-10 | Dexcom, Inc. | Fault discrimination and responsive processing based on data and context |
| PT3430386T (pt) | 2016-03-18 | 2024-02-01 | Univ La Trobe | Análise voltamperométrica móvel |
| CN114468999A (zh) * | 2016-03-30 | 2022-05-13 | 德克斯康公司 | 用于分析物监测系统的系统、装置和方法 |
| CA3028348A1 (en) * | 2016-07-12 | 2018-01-18 | Ascensia Diabetes Care Holdings Ag | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| CN109199403A (zh) | 2017-07-04 | 2019-01-15 | 爱科来株式会社 | 测定装置、计算机可读取的记录介质以及测定方法 |
| EP3703565B1 (en) * | 2017-11-01 | 2024-04-24 | Waveform Technologies, Inc. | Method for conditioning of a sensor |
| CN108209936A (zh) * | 2017-12-25 | 2018-06-29 | 重庆大学 | 一种皮下植入式血糖仪的自适应校准算法 |
| US11445944B2 (en) | 2019-02-22 | 2022-09-20 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for analyte concentration monitoring using harmonic relationships |
-
2020
- 2020-02-04 CN CN202080016885.8A patent/CN113490454A/zh active Pending
- 2020-02-04 JP JP2021545766A patent/JP7494194B2/ja active Active
- 2020-02-04 WO PCT/EP2020/052673 patent/WO2020161099A1/en not_active Ceased
- 2020-02-04 EP EP24186158.2A patent/EP4417124A3/en active Pending
- 2020-02-04 EP EP20704796.0A patent/EP3920798B1/en active Active
- 2020-02-05 TW TW109103528A patent/TWI839458B/zh active
- 2020-02-05 US US16/782,974 patent/US11737688B2/en active Active
- 2020-02-05 US US16/783,080 patent/US11547330B2/en active Active
- 2020-02-05 TW TW113111424A patent/TWI882745B/zh active
-
2024
- 2024-05-21 JP JP2024082492A patent/JP7730951B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120283538A1 (en) * | 2011-05-06 | 2012-11-08 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
| CA3061574A1 (en) * | 2017-07-03 | 2019-01-10 | F. Hoffmann-La Roche Ag | Method and electronics unit for detecting in-vivo properties of a biosensor |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3920798B1 (en) | 2024-08-14 |
| JP2022519854A (ja) | 2022-03-25 |
| US20200245911A1 (en) | 2020-08-06 |
| CN113490454A (zh) | 2021-10-08 |
| US11547330B2 (en) | 2023-01-10 |
| US11737688B2 (en) | 2023-08-29 |
| TW202430097A (zh) | 2024-08-01 |
| TW202045095A (zh) | 2020-12-16 |
| EP4417124A3 (en) | 2024-11-13 |
| JP2024105663A (ja) | 2024-08-06 |
| EP4417124A2 (en) | 2024-08-21 |
| JP7494194B2 (ja) | 2024-06-03 |
| TWI882745B (zh) | 2025-05-01 |
| EP3920798A1 (en) | 2021-12-15 |
| WO2020161099A1 (en) | 2020-08-13 |
| US20200245912A1 (en) | 2020-08-06 |
| JP7730951B2 (ja) | 2025-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI839458B (zh) | 在連續葡萄糖監測（ｃｇｍ）測量期間補償誤差的方法、製造ｃｇｍ裝置的方法及ｃｇｍ裝置 | |
| EP4192348B1 (en) | Non-steady-state determination of analyte concentration for continuous glucose monitoring by potential modulation |